NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/09/2026
Back to search
Official data from USPTO
NCOUNTER SPRINT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NCOUNTER SPRINT
ST13
US500000086357017Class
1, 5, 9
Filing
86357017
Registration
5124745
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
04/28/2026
Trademark type
Word
Nice classes
1, 5, 9
Filing date
08/04/2014
Registration date
01/17/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2015-09-00
First use in commerce
2015-09-00
Drawing code
4
Owner type
03
Owner location
BILLERICA, MA, US
Examiner
REEVES, APRIL ELIZABETH
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BRUKER SPATIAL BIOLOGY, INC.
NanoString Technologies, Inc.
Representatives
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagentsslidessolid matrix materialsmicrofluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory usereagents for proteomicsRNA transcription and microRNA expression profilingsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectorsreagents for scientific or medical research usediagnostic preparations and reagents for scientific or research usesRNA transcription profilingproteomicsclinical diagnosticsenvironmental monitoringbiosurveillanceagricultural inspectionforensic testing of samples containing microorganisms or human fluidssmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; test kitsconsisting of chemical preparations for scientific purposesin particular for the detectiondiagnosisprogress monitoring and progress prediction of diseasesincluding inflammationsinfectionsdisorders of the central nervous systemscardiovascularneurologicalendocrineautoimmune and genetic disorders and cancers; assaysreagentsenzymespolymerasesbuffers and nucleotideskits comprised thereofall for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectorsdiagnostic reagents for scientific in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing
Class 5
diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogenscomprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samples detecting the presence of analytes in samples and identifying sample typesold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profilingproteomicssmall molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health caremedical diagnostic reagents and diagnostic reagents for clinical or medical laboratory usediagnostic reagents for medical in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Class 9
computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific researchfor collectingprocessingtaking images of data in connection with scientific or medical researchthe use of diagnostic preparations and reagents for scientific or research useRNA transcription and microRNA expression profilingproteomicsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsanalysis of functional pathway gene setsmonitoring of biofuel productionprognosticpredictiveclinicaloncologyhematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipmentfluidics stationshybridisation ovenscartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquireanalyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functionsfor capturing fluorescent signalsfor extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research usefor use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samplesdetecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devicesreportstest resultsresearch materialworksheets and other non-printed documents and publicationsall being downloadable
Publications
History of USPTO decisions and trademark events.
50 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/09/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/09/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/09/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
01/29/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/17/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/04/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/29/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/29/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/25/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/17/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/18/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/17/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/13/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/18/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/17/2016
EX2G
SOU EXTENSION 2 GRANTED
11/17/2016
IUAF
USE AMENDMENT FILED
11/07/2016
EXT2
SOU EXTENSION 2 FILED
11/07/2016
EEXT
SOU TEAS EXTENSION RECEIVED
11/07/2016
EISU
TEAS STATEMENT OF USE RECEIVED
11/07/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/10/2016
EX1G
SOU EXTENSION 1 GRANTED
06/09/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/09/2016
EXT1
SOU EXTENSION 1 FILED
05/13/2016
EEXT
SOU TEAS EXTENSION RECEIVED
05/13/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/17/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/22/2015
PUBO
PUBLISHED FOR OPPOSITION
09/22/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/19/2015
ALIE
ASSIGNED TO LIE
08/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2015
NREV
NOTICE OF REVIVAL - E-MAILED
07/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2015
PETG
PETITION TO REVIVE-GRANTED
07/10/2015
PROA
TEAS PETITION TO REVIVE RECEIVED
07/10/2015
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
06/22/2015
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06/22/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/24/2014
GNRT
NON-FINAL ACTION E-MAILED
11/24/2014
CNRT
NON-FINAL ACTION WRITTEN
11/24/2014
DOCK
ASSIGNED TO EXAMINER
11/17/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
08/14/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/13/2014
NWAP
NEW APPLICATION ENTERED
08/07/2014
Continuous trademark protection
Get notified about every new filing that threatens NCOUNTER SPRINT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.